Lululemon Stock Has Been Absolutely Demolished. Time to Buy?

Lululemon Athletica (NASDAQ: LULU) shares plunged following its Q2 earnings report, which saw revenue grow 7% to $2.53 billion and EPS at $3.10, but was overshadowed by a significantly lowered full-year outlook. The company revised its full-year revenue guidance to $10.85-11.0 billion and EPS to $12.77-12.97, citing increased tariff costs and a 3% constant currency comparable sales decline in the crucial U.S. market, despite strong 13% international growth. While the sell-off is viewed as an expectation reset rather than a fundamental business issue, the U.S. segment's underperformance and ongoing tariff pressures create near-term headwinds, leading analysts to advise caution until U.S. comparable sales trends stabilize.

Analysis

Lululemon Athletica's (LULU) significant stock price decline reflects a material reset in forward expectations rather than a fundamental breakdown of the business model. The company's Q2 revenue growth slowed to 7% year-over-year, and a more concerning 3% constant currency comparable sales decline was reported in its core Americas segment, worsening from a 1% decline in Q1. This domestic weakness, attributed to a stale product assortment, contrasts sharply with a robust 13% constant currency comparable sales growth in international markets. The primary catalyst for the sell-off was a substantial downward revision of full-year guidance, with expected EPS cut from a range of $14.58-$14.78 to $12.77-$12.97. Management attributes these headwinds to two key factors: softer U.S. demand and margin pressure from tariff changes and the removal of the de minimis exemption. While the sell-off has compressed the valuation to a more attractive 13 times forecasted 2025 EPS, near-term uncertainty remains high, with recovery contingent on stabilizing U.S. sales, improving gross margins, and managing inventory without significant markdowns.

Key Decisions for Investors

• Investors should exercise caution and monitor for a stabilization in U.S. comparable sales trends over the next two quarters as a key signal that the product assortment refresh is succeeding.
• Scrutinize upcoming reports for sequential gross margin improvement, which would indicate the company is effectively mitigating tariff costs and maintaining pricing discipline without resorting to value-eroding promotions.
• While the current valuation at 13x forecasted 2025 EPS may appear attractive, initiating a position should be weighed against clear execution risks in the U.S. and external tariff policy uncertainty.